Summary & Overview
CPT 0330U: Bridge Women’s Health 27-Pathogen Vaginal NAAT
Headline: New PLA CPT code 0330U identifies a 27-pathogen NAAT for vaginal infections
Lead: CPT code 0330U designates the Bridge Women’s Health Infectious Disease Detection Test, a proprietary nucleic acid amplification test (NAAT) for detecting 27 vaginal pathogens from a vaginal swab. The code enables clear reporting for a single manufacturer’s assay and supports national tracking of molecular testing for common vaginal infections.
Why it matters: As molecular diagnostics expand, PLA codes like 0330U provide specificity for payer adjudication, utilization monitoring, and clinical decision support. Accurate reporting affects coverage determination, claims processing, and surveillance of common reproductive tract infections.
Payers covered: This analysis addresses major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
What readers will learn: The publication explains the clinical scope of CPT code 0330U, typical service context (laboratory NAAT on vaginal swab specimens), and the significance of PLA designation. It summarizes expected topics readers can use: code definition and clinical context, payer coverage considerations, common modifiers used in lab billing, and implications for billing workflows and test reporting. Where input lacks details, the publication notes missing specifics as “Data not available in the input.”
Billing Code Overview
CPT code 0330U is a Proprietary Laboratory Analyses (PLA) code for the Bridge Women’s Health Infectious Disease Detection Test produced by Bridge Diagnostics. This nucleic acid amplification test (NAAT) evaluates a vaginal swab specimen for the presence or absence of 27 vaginal pathogens, including bacteria such as Gardnerella vaginalis, various Candida species (yeast), and Trichomonas vaginalis (TV).
Service type: Laboratory testing — molecular diagnostic NAAT
Typical site of service: Clinical laboratory or outpatient collection site where vaginal swab specimens are collected and submitted to the performing laboratory for analysis.
Clinical & Coding Specifications
Clinical Context
A reproductive-age female presents to an outpatient gynecology clinic with symptoms of vaginal discharge, odor, itching, or pelvic discomfort. The clinician performs a pelvic exam and collects a vaginal swab specimen for nucleic acid amplification testing (NAAT). The specimen is sent to Bridge Diagnostics for the Bridge Women’s Health Infectious Disease Detection Test reported with CPT code 0330U. Results identify the presence or absence of a panel of 27 vaginal pathogens (for example, Gardnerella vaginalis, Candida species, and Trichomonas vaginalis) to guide targeted antimicrobial or antifungal therapy and to inform partner management and counseling. Typical site of service is an outpatient clinic, physician office, urgent care center, or ambulatory specimen collection site where pelvic exams and swab collection are performed. The clinical workflow includes patient history and exam, specimen collection, laboratory requisition and shipment to the performing laboratory, result reporting into the electronic health record, and subsequent treatment planning or follow-up testing as indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Regular, unmodified service | Use when no modifier applies and the test is billed normally by the performing laboratory. |